Patients with clinical symptoms (define as palpable mass, nipple discharge, asymmetric thickening or nodules, and abnormal skin changes)
Patients undergoing full sequence BMRI examination
Through the follow-up database, at least 6 months of follow-up results can be obtained to determine whether the diagnosis result is negative/benign/malignant; for patients who need pathological biopsy, the pathological biopsy results shall prevail to determine the lesion benign/malignant
You may not be if
The breast had received radiotherapy, chemotherapy, biology and other treatments before BMRI.
There are contraindications for breast-enhanced MRI examinations such as allergy to contrast agents.
A prosthesis is implanted in the affected breast.
Patients during lactation or pregnancy
Clareo Health | Artificial Intelligence Analysis for Magnetic Resonance Imaging in Screening and Diagnosis of Breast Cancer
